Skip to content

Everolimus

Everolimus (Afinitor) is a medicine used to treat renal cell carcinoma and breast cancer. This page covers the one tablet formulation listed in the catalogue.

Afinitor

Renal Cell Carcinoma, Breast Cancer

5mg

Everolimus tablets for renal cell carcinoma and breast cancer. It blocks mTOR, a protein that controls cell growth and blood vessel formation in tumours.

From$43.64/ tabletView

Key points

  • Everolimus is an mTOR inhibitor that works by blocking a protein cancer cells need to grow.
  • The originator brand is Afinitor, marketed by Novartis; the catalogue lists one generic formulation.
  • The listed product is a 5 mg tablet.

How Everolimus works

everolimus blocks a protein called mTOR that cancer cells need to grow and divide. This action can slow or stop the spread of cancer cells in the body.

Further reading